← Who reports today · Health Care
ZBH earnings date & Q2 2026 results · Zimmer Biomet
US GAAP · $M · vs Q2 2025 · quarter ended 06/30/2026 · reported 08/05/2026
Zimmer Biomet Holdings, Inc. is a publicly traded American medical device company. · Text: Wikipedia, CC BY-SA 4.0, abridged
More about the company
It was founded in 1927 to produce aluminum splints. The firm is headquartered in Warsaw, Indiana, where it is part of the medical devices business cluster.
Key growth driver: Revenue growth of +5% y/y — the report gives no segment split, so the driver is the whole business. · by the Q2 2026 report
When is ZBH’s next earnings date?
Wednesday, November 4, 2026estimated
Expected around Nov 4 — based on last year’s report on Nov 5, 2025. We have not yet seen the company's announcement of the date.
How we estimate
The estimate is the date of the same-quarter report a year ago, per the company’s SEC filing, moved forward 52 weeks (same weekday). Companies usually keep the same week; the date will be replaced once ZBH announces it.
Same quarter a year ago (ended September 30, 2025): revenue $2B, EPS (GAAP) $1.16
How we calculate
Year-ago figures are GAAP, from the company's SEC filings (XBRL); EPS is diluted.
What time does ZBH report? Usually before market open: the last 4 results releases reached the SEC at 6:30 am, 6:30 am, 6:30 am, 6:30 am ET.
Last report: Aug 5, 2026 (Q2 2026) — broken down in the Sankey chart below. Dates: company announcements; past dates and times — SEC 8-K filings. Who else reports this week →
All figures in $M.
Revenue
$2,177
+4.8%
Operating income
$326
+8.7%
15.0% margin
Net income
$198
+29.8%
$1.03/sh · 9.1% margin
Verdict: revenue grew 4.8% y/y to $2.18B, operating margin 15.0% vs 14.4%, net income $198M (+29.8% y/y).
Operating cash flow was $447.9 million and free cash flow was $308.3 million.
Source and notation
Source: Zimmer Biomet press release, 8-K EX-99.1 of 08/05/2026 (SEC EDGAR). Every figure was matched against the income statement in the release and checked against SEC XBRL.
Open the chart as a PNG image ↗ · for sharing and presentations · free to reuse, CC BY 4.0
ZBH earnings history: past report dates
| Aug 5, 2026 Wed | 6:30 ambefore market open | Jun 30, 2026 | $2.2B+5% y/y | $1.03+34% y/y |
| Apr 28, 2026 Tue | 6:30 ambefore market open | Mar 31, 2026 | $2.1B+9% y/y | $1.22+34% y/y |
| Feb 10, 2026 Tue | 6:30 ambefore market open | Dec 31, 2025 | ≈$2.2B+11% y/y | ≈$0.71−40% y/y |
| Nov 5, 2025 Wed | 6:30 ambefore market open | Sep 30, 2025 | $2.0B+10% y/y | $1.16−6% y/y |
| Aug 7, 2025 Thu | 6:30 ambefore market open | Jun 30, 2025 | $2.1B+7% y/y | $0.77−35% y/y |
| May 5, 2025 Mon | 6:30 ambefore market open | Mar 31, 2025 | $1.9B+1% y/y | $0.91+8% y/y |
| Feb 6, 2025 Thu | 6:30 ambefore market open | Dec 31, 2024 | ≈$2.0B+4% y/y | ≈$1.18−41% y/y |
| Oct 30, 2024 Wed | 6:30 ambefore market open | Sep 30, 2024 | $1.8B+4% y/y | $1.23+60% y/y |
| Aug 7, 2024 Wed | 6:30 ambefore market open | Jun 30, 2024 | $1.9B+4% y/y | $1.18+18% y/y |
| May 2, 2024 Thu | 6:30 ambefore market open | Mar 31, 2024 | $1.9B+3% y/y | $0.84−24% y/y |
| Feb 8, 2024 Thu | 6:37 ambefore market open | Dec 31, 2023 | ≈$1.9B+6% y/y | ≈$2.00 |
| Nov 7, 2023 Tue | 6:30 ambefore market open | Sep 30, 2023 | $1.8B+5% y/y | $0.77−16% y/y |
| Aug 1, 2023 Tue | 6:30 ambefore market open | Jun 30, 2023 | $1.9B+5% y/y | $1.00+37% y/y |
| May 2, 2023 Tue | 6:30 ambefore market open | Mar 31, 2023 | $1.8B+10% y/y | $1.11 |
| Feb 3, 2023 Fri | 6:31 ambefore market open | Dec 31, 2022 | ≈$1.8B+3% y/y | ≈−$0.62−55% y/y |
| Nov 2, 2022 Wed | 6:31 ambefore market open | Sep 30, 2022 | $1.7B−1% y/y | $0.92+33% y/y |
| Aug 2, 2022 Tue | 6:30 ambefore market open | Jun 30, 2022 | $1.8B+1% y/y | $0.73+9% y/y |
| Apr 28, 2022 Thu | 8:30 ambefore market open | Mar 31, 2022 | $1.7B+4% y/y | $0.07−93% y/y |
| Feb 7, 2022 Mon | 6:38 ambefore market open | Dec 31, 2021 | ≈$1.8B−15% y/y | ≈−$0.40 |
| Nov 4, 2021 Thu | 6:45 ambefore market open | Sep 30, 2021 | $1.7B−13% y/y | $0.69−41% y/y |
| Aug 3, 2021 Tue | 6:45 ambefore market open | Jun 30, 2021 | $1.8B+44% y/y | $0.67 |
| May 4, 2021 Tue | 6:46 ambefore market open | Mar 31, 2021 | $1.6B−10% y/y | $0.94 |
| Feb 5, 2021 Fri | 6:48 ambefore market open | Dec 31, 2020 | $2.1B−2% y/y | $1.59+3% y/y |
| Nov 6, 2020 Fri | 6:45 ambefore market open | Sep 30, 2020 | $1.9B+2% y/y | $1.16−44% y/y |
| Aug 4, 2020 Tue | 6:45 ambefore market open | Jun 30, 2020 | $1.2B−38% y/y | −$1.00 |
| Apr 8, 2020 Wed | 4:36 pmafter market close | Mar 31, 2020 | $1.8B−10% y/y | −$2.46 |
| Feb 4, 2020 Tue | 6:29 ambefore market open | Dec 31, 2019 | $2.1B+3% y/y | $1.54 |
| Nov 5, 2019 Tue | 6:32 ambefore market open | Sep 30, 2019 | $1.9B+3% y/y | $2.08+163% y/y |
| Jul 26, 2019 Fri | 6:11 ambefore market open | Jun 30, 2019 | $2.0B−1% y/y | $0.65−28% y/y |
| Apr 26, 2019 Fri | 6:19 ambefore market open | Mar 31, 2019 | $2.0B−2% y/y | $1.20+41% y/y |
| Feb 1, 2019 Fri | 6:15 ambefore market open | Dec 31, 2018 | $2.1B+0% y/y | −$4.42 |
| Oct 26, 2018 Fri | 6:04 ambefore market open | Sep 30, 2018 | $1.8B+1% y/y | $0.79+65% y/y |
| Jul 27, 2018 Fri | 6:15 ambefore market open | Jun 30, 2018 | $2.0B+3% y/y | $0.90+0% y/y |
| Apr 26, 2018 Thu | 6:07 ambefore market open | Mar 31, 2018 | $2.0B+2% y/y | $0.85−42% y/y |
| Jan 30, 2018 Tue | 7:09 ambefore market open | Dec 31, 2017 | $2.1B+3% y/y | $6.03 |
| Nov 1, 2017 Wed | 7:00 ambefore market open | Sep 30, 2017 | $1.8B−1% y/y | $0.48−38% y/y |
| Jul 11, 2017 Tue | 4:41 pmafter market close | Jun 30, 2017 | $1.9B+1% y/y | $0.90 |
| Apr 27, 2017 Thu | 7:44 ambefore market open | Mar 31, 2017 | $2.0B+4% y/y | $1.47+172% y/y |
| Jan 10, 2017 Tue | 7:41 ambefore market open | Dec 31, 2016 | $2.0B+4% y/y | $0.34−45% y/y |
| Oct 31, 2016 Mon | 7:41 ambefore market open | Sep 30, 2016 | $1.8B+4% y/y | $0.78+609% y/y |
| Jul 28, 2016 Thu | 7:54 ambefore market open | Jun 30, 2016 | $1.9B+66% y/y | −$0.16+84% y/y |
| Apr 28, 2016 Thu | 7:40 ambefore market open | Mar 31, 2016 | $1.9B+68% y/y | $0.54−45% y/y |
| Jan 28, 2016 Thu | 7:37 ambefore market open | Dec 31, 2015 | $1.9B+58% y/y | $0.62−30% y/y |
| Oct 29, 2015 Thu | 7:36 ambefore market open | Sep 30, 2015 | $1.8B+59% y/y | $0.11−89% y/y |
| Jul 30, 2015 Thu | 7:38 ambefore market open | Jun 30, 2015 | $1.2B−1% y/y | −$1.00 |
| Apr 30, 2015 Thu | 7:36 ambefore market open | Mar 31, 2015 | $1.1B−2% y/y | $0.99−23% y/y |
| Jan 29, 2015 Thu | 7:13 ambefore market open | Dec 31, 2014 | $1.2B−1% y/y | $0.89−35% y/y |
| Oct 23, 2014 Thu | 7:35 ambefore market open | Sep 30, 2014 | $1.1B+3% y/y | $1.01+12% y/y |
| Jul 24, 2014 Thu | 7:36 ambefore market open | Jun 30, 2014 | $1.2B+1% y/y | $1.01+13% y/y |
| Apr 24, 2014 Thu | 7:08 ambefore market open | Mar 31, 2014 | $1.2B+2% y/y | $1.29+1% y/y |
| Jan 30, 2014 Thu | 7:36 ambefore market open | Dec 31, 2013 | $1.2B+5% y/y | $1.36+55% y/y |
| Oct 24, 2013 Thu | 7:10 ambefore market open | Sep 30, 2013 | $1.1B+5% y/y | $0.90−12% y/y |
| Jul 25, 2013 Thu | 7:25 ambefore market open | Jun 30, 2013 | $1.2B+4% y/y | $0.89−27% y/y |
| Apr 25, 2013 Thu | 7:16 ambefore market open | Mar 31, 2013 | $1.1B−0% y/y | $1.28+9% y/y |
| Jan 31, 2013 Thu | 7:15 ambefore market open | Dec 31, 2012 | $1.2B+1% y/y | $0.88+1% y/y |
| Oct 25, 2012 Thu | 7:16 ambefore market open | Sep 30, 2012 | $1.0B−1% y/y | $1.02+1% y/y |
| Jul 26, 2012 Thu | 7:23 ambefore market open | Jun 30, 2012 | $1.1B−1% y/y | $1.22+15% y/y |
| Apr 26, 2012 Thu | 7:16 ambefore market open | Mar 31, 2012 | $1.1B+2% y/y | $1.17+8% y/y |
| Jan 26, 2012 Thu | 7:16 ambefore market open | Dec 31, 2011 | $1.2B | $0.87 |
| Oct 27, 2011 Thu | 7:19 ambefore market open | Sep 30, 2011 | $1.0B | $1.01 |
Show all 60 reports since 2011Show fewer
How we count
Report date and time — when the company filed its results press release with the SEC (Form 8-K, Item 2.02); the regular session runs 9:30 am – 4:00 pm ET. Companies that file the 8-K late in the evening publish the release the next morning: the date is that morning, before market open, and the evening filing time is not shown. Revenue and diluted EPS — the company’s XBRL filings, EPS adjusted for stock splits; ≈ — fourth quarter derived as full year minus three quarters. Source: SEC EDGAR.
Zimmer Biomet: 15-year financials
| 2025 | 8,232 | 1,098 | 705 | 1,473 | 190 |
| 2024 | 7,679 | 1,286 | 904 | 1,296 | 196 |
| 2023 | 7,394 | 1,278 | 1,024 | 1,291 | 201 |
| 2022 | 6,940 | 696 | 231 | 1,168 | 201 |
| 2021 | 6,827 | 860 | 402 | 1,356 | 200 |
| 2020 | 6,128 | 83.1 | −139 | 1,093 | 199 |
| 2019 | 7,982 | 1,138 | 1,132 | 1,379 | 197 |
| 2018 | 7,933 | 33.8 | −379 | 1,585 | 195 |
| 2017 | 7,803 | 799 | 1,814 | 1,426 | 194 |
| 2016 | 7,668 | 821 | 306 | 1,448 | 188 |
| 2015 | 5,998 | 467 | 147 | 682 | 157 |
| 2014 | 4,673 | 1,037 | 720 | 916 | 146 |
| 2013 | 4,623 | 1,069 | 780 | 863 | 132 |
| 2012 | 4,472 | 1,047 | 755 | 1,037 | 94.4 |
| 2011 | 4,452 | 1,024 | 761 | 1,063 | — |
Show all 15 yearsShow fewer
$ millions, annual 10-K reports on SEC EDGAR (US GAAP)*.
How we calculate
Figures are annual report lines; if a year was later restated (discontinued operations, mergers), we use the latest filing that shows it. Free cash flow is operating cash flow minus capital expenditures; dividends are cash paid to common shareholders during the year. “—” means the line isn’t in the filing. The table starts in 2011; where the listed issuer changed (holding reorganization, redomicile), earlier years come from the predecessor’s filings.
Shareholders’ equity at Jun 30, 2026: $12.6B (55% of total assets). Compare with other S&P 500 companies →
Included in screener lists: S&P 500 companies that paid dividends 10 years without a gap · S&P 500 companies shrinking their share count
Zimmer Biomet (ZBH) earnings: FAQ
When is ZBH's next earnings date?
We have not yet seen an announcement of the date from Zimmer Biomet (ZBH). Based on last year's report on Nov 5, 2025, the next report is expected around Nov 4, 2026.
What time does ZBH report earnings?
Zimmer Biomet usually reports before market open: its latest results release was filed with the SEC at 6:30 am ET on Aug 5, 2026.
When did ZBH last report earnings?
Zimmer Biomet reported Q2 2026 results on Aug 5, 2026.
Where can I find Zimmer Biomet's financial statements?
On SEC EDGAR: quarterly reports (10-Q), the annual report (10-K) and earnings releases (8-K). The “Verified” badge next to the chart links to ZBH's filings; this page breaks the latest report down in a Sankey chart.
What was ZBH's net income in Q2 2026?
Zimmer Biomet reported net income of $198M for Q2 2026 (+29.8% year over year), under US GAAP.
Does Zimmer Biomet pay dividends?
Yes. In 2025, Zimmer Biomet paid $190M in dividends on its common stock, per its 10-K. Earlier years are in the 15-year table above.
How has Zimmer Biomet's revenue changed since 2011?
Per its 10-K filings, revenue grew 1.8x: $4,452M in 2011 and $8,232M in 2025. The latest year is the highest in the table. Year-by-year figures are in the table above.
New to earnings reports? Start with how to read an earnings report.
How this page was made: the figures come from the company's own report on SEC EDGAR; the summary and nuances were drafted by our model from that report — two independent automated readings of the release had to match, and every number in the text was checked against it. Figures checked against the filing on 10/16/2026. How we make the breakdowns · Report an error
More reports: A · Q3 FY2026 · ABBV · Q2 2026 · ABT · Q2 2026 · ALGN · Q2 2026 · AMGN · Q2 2026 · BDX · Q3 FY2026 · BMY · Q2 2026 · BSX · Q2 2026 · CI · Q2 2026 · CNC · Q2 2026 · all reports